Photo: Chaun Harper and Dr. Lucy Gildea
Mary Kay Inc. announced the appointments of Chaun Harper as senior vice president, chief manufacturing officer and Dr. Lucy Gildea as senior vice president, chief scientific officer.
In their new roles, Harper and Gildea will join the global cosmetics company’s executive team. Harper will assume responsibility for global manufacturing operations, global inventory control, supply planning, transportation and global quality. Gildea will continue to lead Mary Kay Inc.’s research and development operations.
“In a relatively short period of time, both Chaun and Lucy have made significant contributions and proven to be instrumental in Mary Kay’s research, development and supply chain operations,” said Deborah Gibbins, chief operating officer for Mary Kay Inc. “In their new roles as members of the company’s executive team, Chaun and Lucy will work to ensure global and regional alignment of strategy and plans for Mary Kay® products.”
Harper joined Mary Kay Inc. in 2014 as director of Production Operations. According to the company, during his tenure he has been instrumental in creating a culture of continuous improvement at Mary Kay’s manufacturing facility, including dramatically increasing production efficiency and implementing key development opportunities for employees to elevate technical skills and advance their careers. Prior to joining Mary Kay Inc., Harper worked for L’Oréal where he held several positions within both the operations and quality functions.
Gildea has worked to execute the company’s global product strategy and innovation pipeline. She will be key in leading the company innovatively into the next generation. Prior to joining Mary Kay Inc., Gildea spent 15 years at Procter and Gamble, working in health care, oral care, beauty technology and beauty/skin development.